Atorvastatin | Lipitor | Generic Lipitor | The Maher Law Firm | Frank Eidson Attorney At LawLipitor’s generic equivalent, Atorvastatin, might contain specks of glass

Ranbaxy Pharmaceuticals, Atorvastatin’s manufacturer, initiated the recall on November 9th, telling pharmacies to stop dispensing the cholesterol lowering drug due to the possibility of glass specks in the medication.

The FDA (Food and Drug Administration) advised patients to stop taking atorvastatin medicine if their pharmacist confirmed it was from a recalled lot.  Although, after a conference call with pharmacies, the FDA changed their decision, stating that “Yesterday’s statement was poorly phrased, it made people think they should stop taking their medicine.” said Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research.

The Atorvastatin pills “aren’t of the quality we would expect of a drug, but they aren’t risky, either” said Woodcock.

Ranbaxy Pharmaceuticals has stopped manufacturing Lipitor’s generic Atorvastatin while they investigate how the glass specks got into the drug in the first place.

If you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have a right to compensation for your injuries.  The Maher Law Firm and Frank Eidson Attorney At Law would like to help.  We invite you to contact our trial tested dangerous drug attorneys today.

Bookmark and Share

Comments are closed.